Teva Pharmaceutical Industries Ltd (TEVA)
13.01
0.00 (0.00%)
USD |
NYSE |
Apr 24, 16:00
12.85
-0.16
(-1.23%)
After-Hours: 20:00
Teva Pharmaceutical Industries Free Cash Flow (Quarterly): 1.065B for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.065B |
| September 30, 2023 | -144.00M |
| June 30, 2023 | 205.00M |
| March 31, 2023 | -284.00M |
| December 31, 2022 | 831.00M |
| September 30, 2022 | 421.00M |
| June 30, 2022 | -4.00M |
| March 31, 2022 | -206.00M |
| December 31, 2021 | 303.00M |
| September 30, 2021 | 383.00M |
| June 30, 2021 | 105.00M |
| March 31, 2021 | -555.00M |
| December 31, 2020 | 155.00M |
| September 30, 2020 | 164.00M |
| June 30, 2020 | 142.00M |
| March 31, 2020 | 177.00M |
| December 31, 2019 | 419.00M |
| September 30, 2019 | 156.00M |
| June 30, 2019 | -339.00M |
| March 31, 2019 | -13.00M |
| December 31, 2018 | 154.00M |
| September 30, 2018 | 282.00M |
| June 30, 2018 | 26.00M |
| March 31, 2018 | 1.333B |
| December 31, 2017 | 592.00M |
| Date | Value |
|---|---|
| September 30, 2017 | 583.00M |
| June 30, 2017 | 242.00M |
| March 31, 2017 | -66.00M |
| December 31, 2016 | -243.00M |
| September 30, 2016 | 1.24B |
| June 30, 2016 | 788.00M |
| March 31, 2016 | 1.204B |
| December 31, 2015 | 1.367B |
| September 30, 2015 | 923.00M |
| June 30, 2015 | 1.311B |
| March 31, 2015 | 1.169B |
| December 31, 2014 | 1.452B |
| September 30, 2014 | 1.212B |
| June 30, 2014 | 861.00M |
| March 31, 2014 | 673.00M |
| December 31, 2013 | 502.00M |
| September 30, 2013 | 216.00M |
| June 30, 2013 | 650.00M |
| March 31, 2013 | 838.00M |
| December 31, 2012 | 1.25B |
| September 30, 2012 | 799.00M |
| June 30, 2012 | 937.00M |
| March 31, 2012 | 482.00M |
| December 31, 2011 | 1.111B |
| September 30, 2011 | 206.00M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-555.00M
Minimum
Mar 2021
1.065B
Maximum
Dec 2023
157.58M
Average
156.00M
Median
Sep 2019
Free Cash Flow (Quarterly) Benchmarks
| Viatris Inc | 278.50M |
| Alvotech | -77.62M |
| Johnson & Johnson | 5.804B |
| AbbVie Inc | 4.548B |
| Novartis AG | 1.764B |